Literature DB >> 15672251

Inhibition of human lens epithelial B-3 cell proliferation by adenovirus-mediated transfer of antisense c-myc construct.

Jie Sun1, Lixin Xie, Yao Wang, Ting Liu.   

Abstract

PURPOSE: To investigate the effects of adenovirus-mediated transfer of antisense c-myc construct on human lens epithelial B-3 (HLE B-3) cell proliferation, apoptosis and cell cycle.
METHODS: HLE B-3 cell cultures were transduced with replication-defective adenovirus bearing either a nuclear-targeted beta-galactosidase (Ad-lacZ) or an antisense c-myc construct (Ad-AS-myc). The presence of beta-galactosidase activity in the transduced cultures was detected by immunohistochemical X-Gal staining, while c-myc mRNA and protein expression levels were evaluated by RT-PCR and Western blot analysis. HLE B-3 cell proliferation within 96 h after the transduction was analyzed by cell counting and MTT colorimetric assay. Apoptosis and cell cycle of the HLE-B3 cells were examined by flow-cytometric analysis.
RESULTS: The mean transduction efficiency was 80% for HLE B-3 cells. Downregulation of c-myc mRNA and protein expression was noticed at 48, 96 and 144 h after the transduction with Ad-AS-myc. Cytostatic effects of Ad-AS-myc in HLE B-3 cells were obvious within 96 h after the transduction. An increased incidence of apoptosis and G1-phase arrest was identified in the Ad-AS-myc-transduced HLE B-3 cells.
CONCLUSIONS: HLE B-3 cells were successfully transduced with adenovirus-mediated antisense c-myc construct. Ad-AS-myc transduction could significantly inhibit cell proliferation and induce cell apoptosis and G1-phase arrest in HLE B-3 cells. It may provide a novel approach for prevention of posterior capsular opacification.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15672251     DOI: 10.1007/s00417-004-1095-4

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  18 in total

1.  Prevention of secondary cataract by antimitotic drugs: experimental study.

Authors:  M M Ismail; J L Alió; J M Ruiz Moreno
Journal:  Ophthalmic Res       Date:  1996       Impact factor: 2.892

2.  Incidence of posterior capsule opacification in eyes with and without posterior chamber intraocular lenses.

Authors:  O Nishi
Journal:  J Cataract Refract Surg       Date:  1986-09       Impact factor: 3.351

3.  Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system.

Authors:  U F Legler; D J Apple; E I Assia; E C Bluestein; V E Castaneda; S L Mowbray
Journal:  J Cataract Refract Surg       Date:  1993-07       Impact factor: 3.351

Review 4.  The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth.

Authors:  Stella Pelengaris; Mike Khan
Journal:  Expert Opin Ther Targets       Date:  2003-10       Impact factor: 6.902

5.  A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.

Authors:  C Capeáns; A Piñeiro; F Domínguez; L Loidi; M Buceta; C Carneiro; T Garcia-Caballero; M Sanchez-Salorio
Journal:  Exp Eye Res       Date:  1998-05       Impact factor: 3.467

6.  Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.

Authors:  Fabio Pastorino; Chiara Brignole; Danilo Marimpietri; Gabriella Pagnan; Adriana Morando; Domenico Ribatti; Sean C Semple; Claudio Gambini; Theresa M Allen; Mirco Ponzoni
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

7.  Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model.

Authors:  J B Smith; E Wickstrom
Journal:  J Natl Cancer Inst       Date:  1998-08-05       Impact factor: 13.506

8.  Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.

Authors:  Maria M Simile; Maria R De Miglio; Maria R Muroni; Maddalena Frau; Giuseppina Asara; Silvia Serra; Maria D Muntoni; Maria A Seddaiu; Lucia Daino; Francesco Feo; Rosa M Pascale
Journal:  Carcinogenesis       Date:  2003-11-06       Impact factor: 4.944

9.  Expression of c-myc protooncogene in rat lens cells during development, maturation and reversal of galactose cataracts.

Authors:  Y Wen; S Shu; N J Unakar; I Bekhor
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

10.  Uncoating of adenovirus type 2.

Authors:  M A Mirza; J Weber
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

View more
  3 in total

1.  EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification.

Authors:  C Wertheimer; R Liegl; M Kernt; W Mayer; D Docheva; A Kampik; K H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-18       Impact factor: 3.117

2.  Attenuation of human lens epithelial cell spreading, migration and contraction via downregulation of the PI3K/Akt pathway.

Authors:  R Liegl; C Wertheimer; M Kernt; D Docheva; A Kampik; K H Eibl-Lindner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-22       Impact factor: 3.117

3.  EGF-Mediated Overexpression of Myc Attenuates miR-26b by Recruiting HDAC3 to Induce Epithelial-Mesenchymal Transition of Lens Epithelial Cells.

Authors:  Ning Dong; Bing Xu; Jingmei Xu
Journal:  Biomed Res Int       Date:  2018-05-30       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.